DOI:
10.1055/s-00034913
Phlebologie
LinksClose Window
References
Glund S, Stangier J, Schmohl M, Gansser D, Norris S, van Ryn J, Lang B, Ramael S, Moschetti V, Gruenenfelder F, Reilly P, Kreuzer J.
Safety, tolerability and efficacy fo idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double blind phase 1 trial.
Lancet 2015;
386: 680-690.
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.